Issuer · CIK 0001623526

STOK — Stoke Therapeutics, Inc.

Recent filings

Mar 24, 2026·Form 4·Sell$292.4K
STOK/Stoke Therapeutics, Inc.
Allan Jonathan · GENERAL COUNSEL & CORP SEC
32conviction

← Back to all filings

STOK (Stoke Therapeutics, Inc.) — recent insider filings — Form 4 AI